Syndivia

OverviewSuggest Edit

Syndivia is a biotechnology company that develops treatment solutions to cancer patients by leveraging microenvironment and anatomical hallmarks for tumors. It provides APN technology for plasma-stable cysteine conjugation. The company offers DARX and C&R technologies for stochiometric chemical protein fusion and hypoxic and necrotic tumor microenvironment-specific drug release.

TypePrivate
Founded2014
HQIllkirch-Graffenstaden, FR
Websitesyndivia.com

Latest Updates

Employees (est.) (Sept 2020)3
Cybersecurity ratingAMore

Syndivia Office Locations

Syndivia has an office in Illkirch-Graffenstaden
Illkirch-Graffenstaden, FR (HQ)
650 Boulevard Gonthier d'Andernach
Show all (1)

Syndivia Financials and Metrics

Summary Metrics

Founding Date

2014

Syndivia total Funding

$3.9 m

Syndivia latest funding size

$2.27 m

Time since last funding

6 months ago

Syndivia investors

Syndivia's latest funding round in March 2020 was reported to be $2.3 m. In total, Syndivia has raised $3.9 m
Show all financial metrics

Syndivia Cybersecurity Score

Cybersecurity ratingPremium dataset

A

95/100

SecurityScorecard logo

Syndivia Online and Social Media Presence

Embed Graph

Syndivia News and Updates

Syndivia Frequently Asked Questions

  • When was Syndivia founded?

    Syndivia was founded in 2014.

  • How many employees does Syndivia have?

    Syndivia has 3 employees.

  • Who are Syndivia competitors?

    Competitors of Syndivia include AIkido Pharma, Immunochina and Feroscan.

  • Where is Syndivia headquarters?

    Syndivia headquarters is located at 650 Boulevard Gonthier d'Andernach, Illkirch-Graffenstaden.

  • Where are Syndivia offices?

    Syndivia has an office in Illkirch-Graffenstaden.

  • How many offices does Syndivia have?

    Syndivia has 1 office.